share_log

Goldman Sachs Maintains Neutral on Incyte, Raises Price Target to $70

Benzinga ·  Oct 31 01:04  · Ratings

Goldman Sachs analyst Salveen Richter maintains Incyte (NASDAQ:INCY) with a Neutral and raises the price target from $63 to $70.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment